ArticleCancer biology & therapy2020

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT.

Whitney F Handy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.